Skip to main content
SpringerLink
Log in

Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure—A placebo-controlled trial

  • Congestive Heart Failure
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

To evaluate the acute and chronic effects of diuretic monotherapy with 3 mg piretanide bid, 46 patients (pts) with congestive heart failure (NYHA II-III) secondary to coronary artery disease were studied. Within 3 weeks of therapy, the patients lost 1.6 kg body weight. Forty-four patients reported a subjective feeling of improvement. Echocardiographically, a highly significant (p<0.001) reduction of diastolic and systolic diameters was found, as well as an increase of fraction shortening. Chest x-ray indicated a reduction of heart volume from 1012±263 ml to 936±233 ml (p<0.001). The serum potassium level remained unchanged. A subgroup of 26 pts underwent invasive hemodynamic examinations. IV injection of 6 mg piretanide resulted in an acute reduction of pulmonary wedge pressure (pc) from 20.2±5.3 mmHg to 11.9±5.0 mmHg (p<0.001); simultaneously a slight decrease of cardiac index from 3.2±0.6 l/min/m2 to 3.0±0.4 l/min/m2 was observed. Invasive control after 3 weeks of oral therapy showed no decline of the piretanide effect. The exercise tolerance increased clearly from 135±161 Wmin to 249±268 Wmin (p<0.05). A control group of further 14 pts was treated with placebo only and did not show any significant changes of pc (20.0±6.4 mmHg vs. 22.8±19.2 mmHg), exercise tolerance, or other clinical parameters. Thus, the diuretic monotherapy of congestive heart failure with piretanide is highly effective and shows a significant improvement in all clinical and hemodynamic parameters in the absence of any remarkable side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dollery CT, Corr L. Drug treatment of heart failure.Br Heart J 1985;54:234–242.

    PubMed  Google Scholar 

  2. Beller GA, Smith TW, Abelmann WH, et al. Digitalis intoxication. A prospective clinical study with serum level correlations.N Engl J Med 1971;284:989–997.

    PubMed  Google Scholar 

  3. Taylor SH, Storstein L. Diuretics in the treatment of heart failure.Herz 1983;8:11–22.

    PubMed  Google Scholar 

  4. Hesse B, Nielson I, Lund-Jacobsen H. The early effects of intravenous frusemide on central haemodynamics, venous tone and plasma renin activity.Clin Sci Molc Med 1975;49:551–555.

    Google Scholar 

  5. Ikram H. Haemodynamic and hormone response to acute and chronic frusemide therapy in congestive heart failure.Clin Sci 1980;59:443–449.

    PubMed  Google Scholar 

  6. Francis GS, Siegel RM. Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure.Ann Intern Med 1985;103:1–6.

    PubMed  Google Scholar 

  7. Biddle TL, Yu BN. Effect of furosemide on haemodynamics and lung water in acute pulmonary oedema secondary to myocardial infarction.Am J Cardiol 1979;43:86–90.

    PubMed  Google Scholar 

  8. Davidson RM, Goldman J, Whalen RE, et al. Haemodynamic effects of furosemide in acute myocardial infarction.Circulation 1971;44(Suppl II):156.

    Google Scholar 

  9. Dikshit K, Vyden JK, Forrester JS, et al. Renal and extrarenal haemodynamic effects of furosemide in congestive heart failure after myocardial infarction.N Engl J Med 1973;288:1087–1090.

    PubMed  Google Scholar 

  10. Kiely J, Kelly DT, Taylor DR, et al. The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction.Circulation 1973;48:581–587.

    PubMed  Google Scholar 

  11. Bauer U, Frick G, Mouselimis N, et al. Akuter und chronischer effekt von piretanid auf die hämodynamik herzinsuffizienter patienten mit koronarer herzerkrankung.Herz/Kreisl 1983;15:493–500.

    Google Scholar 

  12. Rader B, Smith WW, Barger AR, et al. Comparison of the haemodynamic effects of mercurial diuretics and digitalis in congestive heart failure.Circulation 1964;29:328–345.

    PubMed  Google Scholar 

  13. Stampfer M, Epstein SE, Beiser GD, et al. Haemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function.Circulation 1968;37:900–911.

    PubMed  Google Scholar 

  14. Gupta PS, Dare ML, Piretanide (Hoe 118): A new diuretic in essential hypertension.Curr Ther Res 1981;30:468–476.

    Google Scholar 

  15. Valette H, Hebert JL, Raffestin B, et al. Comparison of haemodynamic effects of furosemide and piretanide in normovolemic patients.J Cardiovasc Pharmacol 1980;2:103–111.

    PubMed  Google Scholar 

  16. Klaus E, Alpermann HG, Caspritz G, et al. Vascular effects of piretanide.Arueim Forsch. (Drug Res) 1983;33:1273–1276.

    Google Scholar 

  17. Teredesai P, Puschett JB. Acute effects of piretanide in normal subjects.Clin Pharmacol Ther 1979;25:331–339.

    PubMed  Google Scholar 

  18. McKee PA, Costelli WP, McNamara PM, et al. The natural history of congestive heart failure; the Framingham study.N Engl J Med 1971;285:1441–1446.

    PubMed  Google Scholar 

  19. Watzke K, Frisch P, Klepzig H. Eine vereinfachte methode der radiologischen herzgrößenbestimmung.Münch Med Wochenschr 1973;47:2146–2150.

    Google Scholar 

  20. Hutcheon DE. Martinez JC. A decade of developments in diuretic drug therapy.J Clin Pharmacol 1986;26:567–579.

    PubMed  Google Scholar 

  21. Marsh JD, Nesto R, Glynn MA, et al. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure.J Cardiovase Pharmacol 1982;4:949–954.

    Google Scholar 

  22. Margini F, Niarchos AP. Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.Am J Cardiol 1980:45:841–847.

    PubMed  Google Scholar 

  23. Hasenfuss G, Holubarsch C, Herzog C et al. Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.Clin Cardiol 1987;10:83–88.

    PubMed  Google Scholar 

  24. Verho M, Heintz B Nelson K, et al. The effects of piretanide on catecholamine metabolism, plasma renin activity and plasma aldosterone: A double blind study versus furosemide in healthy volunteers.Curr Med Res 1985;9:461–474.

    Google Scholar 

  25. Wilson JR, Reichek N, Dunkman WB, et al. Effect of diuresis on the performance of the failing, left ventricle in man.Am J Med 1981;70:234–239.

    PubMed  Google Scholar 

  26. Mierzwiak DS. Acute effects of furosemide on left ventricular contractility in dogs.Arch Int Pharmacodyn 1975;213: 180–185.

    PubMed  Google Scholar 

  27. Gonska BD, Kreuzer H. Diuretische monotherapie der herzinsuffizienz.Dtsch Med Wschr 1985;110:1812–1816.

    PubMed  Google Scholar 

  28. Brater DC, Chennavasin P, Dehmer GJ. Prolonged hemodynamic effect of furosemide, in congestive heart failure.Am Heart J 1984:108:1031–1032.

    PubMed  Google Scholar 

  29. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure. Clinical and neuroendocrine effects of introducing diuretics.Br Heart J 1987;57:17–22.

    PubMed  Google Scholar 

  30. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.Am J Cardiol 1981;47:33–39.

    PubMed  Google Scholar 

  31. Roberts CJC, Homeida M, Roberts F. et al. Effects of piretanide, bumetanide and furosemide on electrolyte and urate excretion, in normal subjects.Br J Clin Pharmacol 1978;6:129–133.

    PubMed  Google Scholar 

  32. Verho M, Rangoonwala B, Dols W, et al. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.Eur J Pharmacol 1984;27:407–411.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center of Cardiovascular Diseases, Rotenburg a.d. Fulda, FRG

    U. Bauer, N. Sultan, K. Cernoch & N. Mouselimis

  2. Cardiology Department, University of Ulm, Robert-Koch-Str. 8, D-7900, Ulm, FRG

    W. Haerer M. D., K. J. Fehske, M. Hetzel, M. Stauch & V. Hombach

Authors
  1. W. Haerer M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Sultan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Cernoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Mouselimis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. J. Fehske
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Hetzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Stauch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V. Hombach
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haerer, W., Bauer, U., Sultan, N. et al. Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure—A placebo-controlled trial. Cardiovasc Drug Ther 4, 515–521 (1990). https://doi.org/10.1007/BF01857763

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857763

Key Words

Search

Navigation